GLP-1 Receptor Agonist Therapy in Patients with Cancer: A Review of Clinical Outcomes
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly used for the management of obesity and type 2 diabetes, including among patients with cancer. Although previous research has mainly focused on cancer incidence, their associations with clinical outcomes after cancer diagnosis remain less well charac...